Market Tracker

07/01 5:16pm ET

Novartis AG (NYSE:NVS)

82.71
Delayed Data
As of 4:02pm ET
 +0.20 / +0.24%
Today’s Change
69.90
Today|||52-Week Range
106.84
-3.87%
Year-to-Date
Novartis' Systemic Mastocytosis Drug Positive in Phase II
5:18pm / Zacks.com - Paid Partner Content
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
Jun 28 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: You Should Be Buying Visa
6:04am / TheStreet.com - Paid Partner Content
Trade-Ideas: Novartis (NVS) Is Today's Pre-Market Leader Stock
Jun 28 / TheStreet.com - Paid Partner Content
3 Reasons To Buy Biogen
Jun 30 / MotleyFool.com - Paid Partner Content
The 5 Best Healthcare ETFs
Jun 26 / MotleyFool.com - Paid Partner Content
Xencor Stock Up On Cancer Drugs Partnership with Novartis
Jun 29 / Zacks.com - Paid Partner Content
Google Billionaire: 7 Game-Changing Tech Innovations to Take Off in 5 to 10 Years
Jun 25 / MotleyFool.com - Paid Partner Content
Why Xencor Inc's Shares Are Skyrocketing Today
Jun 28 / MotleyFool.com - Paid Partner Content
Incyte Gains on Jakafi's Breakthrough Status for Acute GVHD
Jun 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close82.51
Today’s open82.61
Day’s range82.42 - 82.83
Volume1,038,926
Average volume (3 months)2,177,432
Market cap$191.8B
Dividend yield3.29%
Data as of 4:02pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)+77.51%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.35%
Revenue growth (last year)-4.75%
P/E ratio29.5
Price/Sales4.25
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.36+1.02%
AGNPRAAllergan plc+6.08+0.73%
MRKMerck+0.33+0.57%
BMYBristol-Myers Squibb+0.23+0.31%
Data as of 4:00pm ET, 07/01/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$1.20
Annual revenue (last year)$49.4B
Annual profit (last year)$17.8B
Net profit margin14.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts